JHL Becomes Eden And Announces Denosumab Progress

Offers Phase I And III Updates On Biosimilar Rival To Amgen’s Prolia

 
• By David Wallace
Prolia Denosumab Amgen
Eden Biologics is readying a biosimilar rival to Prolia • Source: Shutterstock

More from Biosimilars

More from Products